Evidence map›Paper›PMID 27044339›Full record

ArticleDiabetologia2016

Gaps in life expectancy for people with type 1 diabetes.

Lars C Stene

Abstract readComment
PubMed Publisher
In one paragraph

Article in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Oral Health Status of Children Living with Type 1 Diabetes Mellitus.International journal of environmental research and public health · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Lars C SteneNorwegian Institute of Public Health, P.O. Box 4404, Nydalen, NO-0403, Oslo, Norway. Lars.Christian.Stene@fhi.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two papers in this issue of Diabetologia present recent trends in life expectancy for people with type 1 diabetes, one using data from an Australian registry (Huo et al, DOI: 10.1007/s00125-015-3857-4 ), the other, a Swedish registry (Petrie et al, DOI: 10.1007/s00125-016-3914-7 ). This commentary provides a brief review of the concept of the period life expectancy and complexities regarding applicability to patients, before summarising and discussing the main results of the two papers. In addition, some remaining relevant knowledge gaps are discussed.

Indexed as

AdolescentAdultDiabetes Mellitus, Type 1HumansLife ExpectancyMiddle AgedYoung AdultClinicalClinical epidemiologyEpidemiologyHumanLife expectancyMortalityRegistriesType 1 diabetes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.